Clinical and diagnostic value of ribosomal P autoantibodies in systemic lupus erythematosus
Authors:
Open Access
- 5 June 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 48 (8) , 953-957
Abstract
Objective. To analyse prospectively the diagnostic sensitivity and specificity as well as the clinical relevance of ribosomal P (anti-P) autoantibodies in a large cohort of SLE patients. Methods. The anti-P autoantibodies were evaluated in the serum of 200 Tunisian SLE patients at disease onset and 130 various control subjects by a sensitive immunodot assay. A complete laboratory evaluation and clinical examination were performed in each SLE patient. During the follow-up, the patients were regularly monitored for clinical parameters. Global SLE activity was measured by the ECLAM. Results. The sensitivity and specificity of anti-P testing for SLE were 23.5 and 98.4%, respectively. The anti-P-positive samples 14/47 (29.8%), 27/47 (57.4%) and 5/47 (10.6%) were negative for anti-dsDNA, anti-Sm or both antibodies, respectively. The anti-P-positive patients showed more active disease activity and a much higher prevalence of arthritis. An association between IgG aCLs and anti-P antibodies was also found. However, anti-P antibodies were not associated with neuropsychiatric manifestations or lupus nephritis. Conclusion. This study does not seem to confirm the described association of anti-P antibodies with neuropsychiatric manifestations of SLE. However, it supports the anti-P antibody association with arthritis and disease activity as well as the presence of aCL. Based on our study and other related studies, we propose that, akin to anti-Sm and anti-dsDNA, anti-P antibodies detected by one agreed method may be considered for inclusion as a criterion for the classification of SLE.Keywords
This publication has 38 references indexed in Scilit:
- Accuracy of anti–ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: An international meta‐analysisArthritis & Rheumatism, 2005
- Anti-ribosomal P protein antibodiesAutoimmunity, 2005
- Technical and clinical evaluation of anti‐ribosomal P protein immunoassaysJournal of Clinical Laboratory Analysis, 2004
- Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodiesAnnals of the Rheumatic Diseases, 2000
- Fluctuations of antibody to ribosomal P proteins correlate with appearance and remission of nephritis in SLELupus, 1996
- Concomitant development of chronic active hepatitis and antibodies to ribosomal p proteins in a patient with systemic lupus erythematosusArthritis & Rheumatism, 1993
- ANTI-P ANTIBODIES ARE ASSOCIATED WITH PSYCHIATRIC AND FOCAL CEREBRAL DISORDERS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUSRheumatology, 1993
- Correlation of antibodies to ribosomal P protein with psychosis in patients with systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1992
- A prospective study on antiribosomal P proteins in two cases of familial lupus and recurrent psychosis.Annals of the Rheumatic Diseases, 1990
- Association between Lupus Psychosis and Antiribosomal P Protein AntibodiesNew England Journal of Medicine, 1987